Try our Advanced Search for more refined results
Life Sciences - July, 2022
298 articles
- The 2022 Regional Powerhouses
- Biden's 1st Circ. Pick, Abortion Rights Atty, Up Against Clock
- 10th Circ. Tosses Sanofi's EpiPen Antitrust Suit Against Mylan
- SEC Says Pharma Adviser Passed Insider Tips To His Family
- Fed. Circ. Won't Nix Revival Of UMass IP Suit Against L'Oreal
- Cannabis Bill Roundup: Congress Kicks Off Reform Agenda
- DQ'd Tenn. Judge Suspended For Media Interviews, Affair
- Post-Dobbs HHS Guidance Brings Privacy Considerations
- Sepsis Testing Trial Ends In $2.1M Patent Verdict In Del.
- USPTO Clarifies IP Disclosure Duties Amid Drug Pricing Push
- Hatch-Waxman Allowed Prevacid IP Suit, Takeda Tells 3rd Circ.
- In-House At A Cannabis Company
- In-House At A Cannabis Company: The Int'l Trademark Issues
- 2nd Circ. Backs NY Schools' 2019 Update To Vaccine Rules
- Cross-Border M&A Atty Joins Norton Rose's NY Practice
- S. Africa Targets EU Citrus Regs With First-Ever WTO Case
- Allergan Reaches Deal To Pay $2.37B To Settle Opioid Suits
- CR Bard's Mesh Design Was Substandard, Patient Says
- Biogen Denies Misleading Investors Over Alzheimer's Drug
- Fed. Circ. Forecast: Nike Returns To Defend A Patent
- JPML Mulls Individualized Causation In Gardasil Vax Suits
- Abbott Labs' Judge Choice Leads To JPML Conflict Questions
- 2 NJ Firefighters Admit Roles In $50M Drug Fraud Scheme
- HHS Fraud Alert Is A Major Warning To Telehealth Industry
- Albright's Dimmed Power Upsets New Waco Patent Practices
- Ex-UChicago Prof's Insider Trades Merit Prison, Feds Say
- Cos. Should Prepare For Gov't Grantee IP Reporting Update
- Circuit Split On Cannabis Prosecutions Heightens Uncertainty
- NY State Accuses CVS Of Illegal Service Tying
- Justices Must Correct Fed. Circ.'s Overreach On Patents
- Judge Orders Claim Estimation For J&J Talc Unit's Ch. 11
- Fla. Man Charged In $25M Medicare Fraud Scheme
- Senate Advances Bill To Create FDA-USPTO Patent Task Force
- 3M Unit Strikes Deal To Extend Earplug Suit Schedule
- Investors Want To Block $890M Go-Private Sale Of Radius
- Immigration Key To Fixing Semiconductor Scarcity, GAO Says
- FDA Must Enable More Testing To Contain Monkeypox Spread
- Illinois Medical Center Wants Out Of Merger Antitrust Suit
- Ohio Judge Blocks Air Force Vax Requirement Nationwide
- How Lawyers Can Set Ethical Boundaries Post-Pandemic
- Ex-CNA Insurance Atty Jumps To Hinshaw In Chicago
- Vet Slams 3M's Bid To Undo $50M Earplug Injury Verdict
- Biophysics IP Counsel Rejoins Buchanan Ingersoll
- Del. Jury Finds Kurin Infringed Rival's Blood-Testing Patent
- DC Circ. Affirms FDA's Denial Of Flavored Vape Applicants
- Ch. 11 Cheat Sheet: Aearo Technologies
- Pet Owners Say IDEXX Illegally Cornered Test Kit Market
- J&J Unit, Talc Claimants Spar Over Ch. 11 Case's Path
- TTAB Won't Let Radiology Co. Secure 'Your Body' Podcast TM
- Fed. Circ. Won't Rethink USPTO Cancer Patent App Ruling
- Full Fed. Circ. Urged To Reject Hirshfeld's Director Reviews
- 'Baffling' I'm Not Out Of Prison Yet, Ex-Insys Exec Says
- A Lawyer's Guide To Collecting Fees From Nonpaying Clients
- Teva Reaches $5B National Opioid Deal
- Female Atty Sues Former Firm For Sexual Discrimination
- FDA Inaction May Not Doom GSK Zofran MDL, 1st Circ. Hints
- Ex-BakerHostetler IP Partner Joins Blank Rome In DC
- These Law Firms Have The Most Diverse Equity Partnerships
- 3M Unit Seeks Ch. 11 Protection To Settle Earplug Claims
- 2nd Circ. Backs Pfizer Loss In Drug Copay Program Suit
- BioNTech, Pfizer Say They Didn't Infringe CureVac Patents
- PE Execs Want Out Of Suit Over Radiology Chain Stock Plan
- J&J Talc Unit, Tort Claimants Clash On Claim Estimation
- WTO Finds Turkey's Pharma Production Measures Unfair
- Amyris Investors' $13.5M Deal Over Inflated Royalties OK'd
- AstraZeneca Says Vidal Memo Backs Case Against Fintiv Rule
- How Lawyers Can Benefit From TikTok Without Being 'Cringe'
- Catching Up With Delaware's Chancery Court
- Patent Drafting Reminders In Fed. Circ. Skin Care Ruling
- Novartis Can't Shake Former Exec's Whistleblower Award
- CR Bard Wants Win Over Rest Of Pelvic Mesh Suit
- NM Patients Say Insurance Should Cover Cannabis
- How Reed Smith Notched A 'Sweeping' Opioid Trial Triumph
- 3 Firms Guide Dutch Biotech Startup's $326M SPAC Merger
- It's Maryland Versus Virginia In A Race To Adult-Use Cannabis
- Amazon, 3M Accuse Sellers Of Counterfeit Stethoscope Scam
- Countersuit Tossed In Hemp Harvesting Machine Dispute
- Ex-GOP Congressman, 8 Others Charged With Insider Trading
- Law360's Diversity Snapshot: What You Need To Know
- 5th Circ. Ends Pharma Group's Medicare Payback Suit
- Eli Lilly Pocketed $60M Meant For Medicaid, Ill. Jury Hears
- After Dobbs: Abortion Battles Hit The Courts, Soon The Polls
- Ex-Medical Device Co. CEO's Double Jeopardy Bid Falls Short
- Texas Court Revives Suit Over Erroneous DNA Test
- Inside A BigLaw-Boutique Alliance Tackling A Post-Roe World
- Ga. Opioid Trial Called Off After COVID-19 Outbreak
- Full Fed. Circ. Urged To Undo 'Extraordinary' Gilenya IP Ruling
- Faegre Drinker Loses Partner To Banner Witcoff
- Sandoz Loses Challenge To FDA Exclusivity For Sanofi Drug
- Ex-UChicago Prof Seeks No Jail Time For Insider Trading
- 7th Circ. Sides With VA On Tech's Disability Retaliation Claims
- Feds Want Role In 4th Circ. Rehearing Of Allergan FCA Case
- How The FTC Is Imposing Monetary Remedies Post-AMG
- 3rd Circ. Backs $1M FBAR Penalty Against Ex-Pharma CEO
- Drugmaker Says FDA Delayed OK Of Narcolepsy Medication
- CBD Extract Co. Says No Jurisdiction In 'Ponzi' Scheme Suit
- Health Hires: Ropes & Gray, BeiGene
- J&J, Ethicon Sink Failure-To-Warn Claim In Pelvic Mesh Trial
- In-House At A Cannabis Company: The Real Estate Issues
- Flint Jury Hears Atty Criticisms In Final Argument
- The Rulings That Quickly Made 2022 Huge For Health Law
- PTAB Judges Discuss Their Approach To New Fintiv Guidance
- SF, Walgreens Continue Opioid Bellwether Battle Post-Trial
- Chancery Approves Bioscience Co. Deal, Splits $850K Fees
- PTAB Mulls Validity Of Novartis Syringe IP In Regeneron Fight
- 3 Firms Guide Biopharma Co. ZyVersa's $109M SPAC Merger
- Crypto Dominos Keep Falling, J&J Wants Talc Injunction
- Must Your Client Pay An Opponent's Expert For Prep Time?
- Chancery Holding Amplifies Approach To Boardroom Issues
- House Passes Contraceptive Bill Post-Dobbs
- 3rd Circ. Finds Perrigo, AbbVie Settlement Bars Antitrust Suit
- Deals Rumor Mill: SoftBank, Porsche, ConocoPhillips
- Split 4th Circ. Clarifies CWA's Prosecution Requirements
- Flint Water Contractors Want 'A Pass,' Jury Hears In Closings
- Ex-Clinic COO's FCA Suit Trimmed, But Heads For Trial
- PTAB Axes Hypertension Drug IP Involved In Generic Fight
- NJ Announces Alliance With Feds To Protect Abortion Access
- Class Claimant Says Imerys Ch. 11 Stay Can't Pause J&J Suit
- Businesses Should Prepare For FTC Use Of Robinson-Patman
- The New Fintiv Guidance: Overcoming Discretionary Denials
- FDA Seeks Outside Help On Food And Tobacco Programs
- BigLaw IP Experts Head For Hoffmann & Baron In DC
- Inform Diagnostics Settles Mass. FCA Probe For $16M
- Impax Inks $145M Deal With Direct Purchasers In Opana MDL
- Jackson Walker Lands Health Care Partner In Houston
- 11th Circ. Lifts Block On Ga. Abortion Ban Law
- Biogen To Pay $900M To Settle Kickback Claims On Trial's Eve
- Feds Say Charges Filed In $1.2B Series Of Health Fraud Cases
- Greenberg Traurig Adds Trade Secrets Pro To Boston Office
- Oblon McClelland Scoops Partner From Dickinson Wright
- Last Flint Trial Witness Says Contractors Met Standards
- 'Sales Were King' For Drug Cos., Says Atty In Ga. Opioid Trial
- Top Product Liability Cases Of 2022: Midyear Review
- Goodwin Adds Partners In Tech M&A, Private Investment Funds
- J&J Wants Opioid Claims From NY Towns, Cities Tossed
- Product Liability Vs. Consumer Fraud: What's The Difference?
- The Biggest Trade Policy Stories Of 2022: Midyear Report
- AMA President Says Doctors Facing Uncertainty Post-Dobbs
- Bar Exam Policies On Menstruation Still Fall Short
- NY Worker's Family Gets $15M In Mesothelioma Verdict
- Coloplast Gets Win In Vaginal Mesh Device Suit
- Foley Hoag Starts Reproductive Health Unit In Wake Of Dobbs
- EU Accuses Illumina Of Jumping Gun On $8B Grail Deal
- FibroGen Can't Dodge Securities Suit Over Anemia Drug
- Drug Cos., Researchers Back Juno's 'Possession' Petition
- Justices Warned That Biogen's Loss Will End Drug Patents
- University Of Ky. Ducks Due Process Claims At 6th Circ.
- Sidley-Advised Diagnostics Co. Raises $225M In Funding
- Federal Circuit Upholds Invalidation Of Kidney Test Patents
- Georgia Says Dobbs Shows State Abortion Ban Is Valid
- Seagen Gets PGR Nixed Under Fintiv In Rehearing Decision
- 7th Circ. Affirms Tossing Of Case Against Ill. Hospital Chain
- Gilstrap Says AstraZeneca Rival Had No Undue Delay In IP Suit
- J&J Elevates Atty To General Counsel As Top Lawyer Retires
- Fee Bid In Bioscience Suit Deal Is Unfair, Chancery Told
- Keys To Crafting Hybrid Work Policies At Law Firms
- Haynes And Boone Adds Lathrop GPM IP Atty In DC
- 7 Firms Guide GSK Spin-Off Haleon In London Listing
- Trucker Wants RICO Claim Revived In Suit Against CBD Co.
- 1st Circ. OKs Pharmacist's 10-Year Term For Deadly Outbreak
- Catching Up With Delaware's Chancery Court
- Biden Scraps Plan To Nominate McConnell-Backed Judge Pick
- Can States Legally Ban FDA-Approved Abortion Pills?
- After Dobbs: The Latest Legal Battle Lines Over Abortion Care
- Impax Investor Attys Score $9.9M Fees In Price-Fixing Suit
- House Passes Bill To Suspend Imported Baby Formula Duties
- Novo Nordisk Hits Biocon With IP Suit Over Weight Loss Drug
- Your AI Program Probably Isn't A Person In A Court Of Law
- Justices Urged To End 'Ominous' Patent Trend In Biogen Case
- In-House At A Cannabis Company: The ESG Issues
- House Passes Bills To Protect Abortion Rights Post-Dobbs
- Patent Cases To Watch In The Second Half Of 2022
- J&J Unit Seeks To Halt Mississippi, New Mexico Talc Suits
- Illumina Pays Complete Genomics $325M To End DNA IP Row
- Bristol-Myers Opts To Drop Suit Rather Than Publish Award
- IP Forecast: 'Pulp Fiction' NFT Feud To Play In LA Court
- Texas Sues Feds Over Emergency Abortion Care Guidance
- How New USPTO Guidance Fine-Tunes Fintiv Application
- Pa. AG Pledges To Defend Abortion Access From Other States
- Ex-Novartis Sales Rep Claims Firing Was Retaliatory
- Republicans Block Bill To Protect Interstate Abortion Travel
- Tips For Handling Audio Data In E-Discovery Post-Pandemic
- Doctors Sue DHS, Medical Boards Over Freedom Of Speech
- Dems Push Biden For Health Emergency On Abortion
- Greenhouse Maker Says Cannabis Grower Infringed Patent
- Winston & Strawn Adds Ex-HHS Regulatory Atty In DC
- ECJ Urged To Rule Servier Agreements Are Anti-Competitive
- Rite Aid Quietly Inks Opioid MDL Deals, Litigation Freeze
- Walgreens Says SF Opioid Case Has 'Fatal Flaw' As Trial Ends
- Joint Juice Seeks Class Decertification After Trial Loss
- Crypto Issues Grow, Mediation Over Abuse OK'd In Ch. 11
- FDA Clears Novavax, Adding Option For COVID Vax Holdouts
- US Patent Takeaways From Russia Sanctions Exemption
- LegitScript To Face PharmacyChecker Suit Over Blacklisting
- Mass. Biotech Biz Gets PTAB To Wipe Alzheimer's Drug Patent
- Immunitas Therapeutics Hires Senda CLO As COO
- Ex-Exec Sues Over Ouster From Vape Product Co.
- GenapSys Cleared For Ch. 11 Loan With Sale Milestones
- Medical Biz Says SPAC Suit Belongs In Delaware, Not Texas
- Arnold & Porter Lands Life Sciences Partner From Reed Smith
- Justices Told Teva Skinny Label Loss 'Eviscerates' Certainty
- Walgreens Allowed Iffy Opioid Orders, SF Says At Trial Wrap
- Mylan Can't Stop AstraZeneca's Asthma Drug Patent Suit
- The Opposing View On Cannabis Legalization
- Ch. 11 Cheat Sheet: GenapSys
- Pfizer, Moderna Face New IP Litigation Over COVID Vaccines
- Catalyst Inks Deal To End Its 'Orphan Drug' Case
- Senate Committee Explores Post-Dobbs Abortion Landscape
- 7th Circ. Affirms Lupron Suit Dismissal As Too Late
- Arthrex Tells Full Fed. Circ. USPTO Can't Cherry-Pick Leader
- Ex-Theranos CEO Holmes' Sentencing Delayed Until October
- Ariz. Abortion Law Stopped For Now On Vagueness Ground
- Strategies For Effectively Marketing Law Firm ESG Practices
- Fee Fight Brewing Over Bioscience Co. Suit Deal In Chancery
- $58M Opioid Deal Cuts Allergan, Teva From SF Bellwether Trial
- GenapSys Opens Ch. 11 After Chancery Shakes Up Board
- Hospitals Must Provide Emergency Abortion Care, Feds Say
- Microsoft's New AI Medical Imaging Biz Defeats Patent Suit
- Zydus Faces Xtandi Cancer Drug Patent Suit
- NY AG Says Teva's Parent Belongs Back In Opioid Case
- Veterinarian Gets 11 Years In Horse Doping Crackdown
- Fla. Mother Claims Tainted Abbott Formula Made Baby Sick
- Justices Urged To Review On-Sale Bar Ruling In Catheter Case
- FDA Asked To Make Birth Control Pill Available OTC
- Venue Issues Drug Cos. Should Watch In Hatch-Waxman Suits
- Monsanto Beats Delaware's Suit Over PCB Contamination
- Catching Up With Delaware's Chancery Court
- Agreement Among Litigants Key To Using E-Discovery Tech
- Notes On Social Equity From A Former Cannabis Regulator
- USPTO Wants Fed. Circ. To Rethink Cancer Patent App Ruling
- 2 Firms Lead $320M Vertex Buy Of Diabetes Treatment Co.
- Cannabis Shops' Racial Bias Suit Over Licenses Tossed
- W.Va. Opioid Verdict Widens Judge-Jury Split On Vital Theory
- Texas Pol Threatens Sidley With Charges Over Abortion Policy
- 4 Takeaways From Ex-Theranos Exec Balwani's Fraud Verdict
- Lens.com Attys Sanctioned For 'Wild Goose Chase' In TM Row
- Chancery Prunes GenapSys Board, Orders Annual Meeting
- How Congress Is Addressing Employment Visa Backlog
- Law Groups Push 3rd Circ. To Toss J&J Bankruptcy Filing
- Judge Approves Deal To End Dr. Oz's 'Miracle' Diet Pills Suit
- Why J&J's Bankruptcy Is Still Alive And InfoWars' Is Not
- How The Pandemic Changed FDA Inspections
- NYS Courts Again Hit With Suit Over Vax Mandate
- Ex-Biotech Co. CEO Sues In Del. For Return Of Yanked Shares
- Biden Orders Agencies To Protect Abortion Access
- Hill-Rom Can't Beat Surgery Table Infringement Claim
- A Former Cannabis Regulator On Shaping A Nascent Industry
- Law School Admissions Shouldn't Hinge On Test Scores
- Flint Water Jury Hears Of Council Meeting Discord
- Invisalign Maker's 'Puffery' Isn't Investor Fraud, 9th Circ. Says
- Fla. Appeals Court Reverses $6M In Damages In Engle Case
- Ex-Medical Device Exec Charged With Insider Trading
- High Court Ruling Boosts Defenses In DOJ Health Care Cases
- GOP Cut Pharma's Taxes Offshore, Senate Report Finds
- Fed. Circ. Wary Of Undoing Endo Loss Over Vasostrict Fight
- 3 Firms Lead Meridian Bioscience's $1.53B Sale
- Actavis Loss In ADHD Drug IP Fight Backed By Fed. Circ.
- BakerHostetler Adds Ex-Winston & Strawn FDA Partner
- Banner Health Promotes Atty To Head Of Legal
- Clark Hill Must Face Claims From Ex-Client, Philly Judge Rules
- Former Theranos Exec Sunny Balwani Convicted Of Fraud
- Deals Rumor Mill: Merck, Sequoia, Ridgeback
- Chancery Won't Consider Firms' Bid To Lead Ionis Pay Suit
- Whistleblower Settles Fraud Case With DHS Contractor
- Justices Urged To Mend Circuit Split Over FCA Scienter
- $12.5M Class Deal Reached In Ionis-Akcea Drug Licensing Suit
- FTC Told Ban On Juul Sales Bolsters Altria Deal Challenge
- An Uncertain Future For HHS Drug Reimbursement Rates
- The Biggest Patent Rulings Of 2022: A Midyear Report
- FDA, USPTO Heads Look At Teaming Up On Drug Pricing
- Embracing Revenue Operations For Strong Law Firm Growth
- FDA Stays Juul Ban, Says More Review Needed
- USPTO Tells Fed. Circ. AIA Allows Gene-Editing Interference
- Biden Planned To Name Anti-Abortion Ky. Judge, Emails Show
- Premium Cigar Groups Get Win In Suit Over FDA Rulemaking
- J&J Talc Unit Headed For Pivotal Ch. 11 Hearing
- Drug Distributors Off Hook In W.Va. Opioid Trial
- Texas Justices Allow Enforcement Of Pre-Roe Abortion Ban
- Supreme Court Embraces Originalism In 'Momentous' Term
- Pro Say & The Term Discuss A Historic Supreme Court Term
- 9th Circ. Clears Calif. City Of Liability In Hazardous Water Suit
- Pa. County Sues Major Pharmacy Chains Over Opioid Controls
- NJ Takes On Dobbs With Passage Of Abortion Rights Laws
- The Firms That Won Big At The Supreme Court
- The Sharpest Dissents From The Supreme Court Term
- The Funniest Moments Of The Supreme Court Term
- Ky. Trial Judge Vacancy Tees Up Likely Biden-McConnell Deal
- FDA Flexes Muscle On Juul And Nicotine, But At What Cost?
- Catching Up With Delaware's Chancery Court
- Make Room For Serendipity In Your Legal Job Search
- Health Hires: Lewis Brisbois, Troutman Pepper
- Pot Co. Canopy Takes CBD Patent Row To Fed. Circ.
- The Fed. Circ. In June: A Few Decisions To Know
- Tepid Equity Markets Start 2nd Half Of '22 On Shaky Ground
- The Chattiest Justice Of The Term Is ...
- Breaking Down The Vote: The High Court Term In Review
- Jury Hands Endo Win In Opana Pay-For-Delay Case
- Ohio Supreme Court Declines To Block 6-Week Abortion Ban